Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More


On CNBC's "Mad Money Lightning Round," Jim Cramer said he is intrigued about Anavex Life Sciences Corp AVXL because Biogen Inc BIIB data doesn't look that good. He sees it as a real spec, but he would stick with it.

Cramer is done with Chinese IPOs. He would sell Nio Inc - ADR NIO.

He doesn't understand a short position in Upstart Holdings Inc UPST.

Market News and Data brought to you by Benzinga APIs
Posted In: Small CapMediaCNBCJim Cramermad money Lightning Round
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!